M2698
| CAS No. | 1379545-95-5 | Cat. No. | BCP19488 |
| Name | M2698 | ||
| Synonyms | M-2698;M 2698; MSC-2363318A; MSC 2363318A; MSC2363318A; | ||
| Formula | C21H19ClF3N5O | M. Wt | 449.86 |
| Description | M2698, also known as MSC-2363318A, is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier. M2698 was highly potent in vitro (IC50 1 nM for p70S6K, Akt1 and Akt3 inhibition; IC50 17 nM for pGSK3β indirect inhibition) and in vivo (IC50 15 nM for pS6 indirect inhibition), and relatively selective (only 6/264 kinases had an IC50 within 10-fold of p70S6K). | ||
| Pathways | PI3K/Akt/mTOR MAPK Pathway | ||
| Targets | RSK AKT | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.